US · UHS · MEDICAL - CARE FACILITIES
Universal Health Services, Inc. (UHS) intrinsic value and stock valuation
$179.43as of 2026-11-21 · Mkt cap 10.39B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Universal Health Services, Inc. DCF and intrinsic value
InvestorsCraft values UHS with the Chepakovich two-stage DCF model — currently rated undervalued. How the model works · Run your own DCF prefilled from UHS’s statements →
Universal Health Services, Inc. Graham Number
Graham Number: $247.78d — the price is at or below the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2011–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- HCA Healthcare, Inc. (HCA) $475.57
- Tenet Healthcare Corporation (THC) $263.19
- Fresenius Medical Care AG & Co. KGaA (FMS) $20.44
- DaVita Inc. (DVA) $161.03
- Encompass Health Corporation (EHC) $133.65
- The Ensign Group, Inc. (ENSG) $176.32
- LifeStance Health Group, Inc. (LFST) $13.82
- Acadia Healthcare Company, Inc. (ACHC) $34.60
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $17.4B | $15.8B | $14.3B | $13.4B | $12.6B |
| Operating income | $1.99B | $1.68B | $1.18B | $1B | $1.36B |
| Net income | $1.49B | $1.14B | $717.8M | $675.6M | $991.6M |
| EPSd | $23.1M | $16.8M | $10.2M | $9.15M | $11.8M |
| Operating cash flow | $1.86B | $2.07B | $1.27B | $996M | $883.7M |
| Capital expenditure | -$-1.02B | -$-943.81M | -$-743.05M | -$-734M | -$-855.66M |
| Free cash flow | $849.3M | $1.12B | $524.7M | $262M | $28M |
| Total assets | $16B | $14.5B | $14B | $13.5B | $13.1B |
| Total debt | $5.51B | $4.96B | $5.37B | $5.27B | $4.56B |
| Net debt | $5.37B | $4.83B | $5.25B | $5.17B | $4.44B |
| Total equity | $7.41B | $6.76B | $6.2B | $5.97B | $6.2B |
| Cash and short-term investments | $137.8M | $126M | $119.4M | $102.8M | $115.3M |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $17.4B | $15.8B | $14.3B | $13.4B | $12.6B |
| Cost of revenue | $1.66B | $1.59B | $1.53B | $1.47B | $1.43B |
| Gross profit | $15.7B | $14.2B | $12.7B | $11.9B | $11.2B |
| Research and development expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Selling, general and administrative expenses | $8.23B | $7.67B | $7.25B | $6.89B | $6.28B |
| Other expenses | $5.48B | $4.89B | $4.33B | $4.03B | $3.57B |
| Operating expenses | $13.7B | $12.6B | $11.6B | $10.9B | $9.85B |
| Cost and expenses | $15.4B | $14.1B | $13.1B | $12.4B | $11.3B |
| Interest income | $1.19M | $1.43M | $570K | $380K | $1.6M |
| Interest expense | $157.3M | $187.5M | $207.3M | $127.3M | $85.3M |
| Depreciation and amortization | $618.7M | $584.8M | $568M | $581.9M | $533.2M |
| Ebitda | $2.74B | $2.27B | $1.72B | $1.58B | $1.91B |
| Operating income | $1.99B | $1.68B | $1.18B | $1B | $1.36B |
| Total other income/expenses, net | -$-21.87M | -$-183.88M | -$-234.96M | -$-137.29M | -$-69.78M |
| Income before tax | $1.97B | $1.5B | $940.4M | $866.3M | $1.29B |
| Income tax expense | $461M | $334.8M | $221.1M | $209.3M | $305.7M |
| Net income | $1.49B | $1.14B | $717.8M | $675.6M | $991.6M |
| Weighted average shares outstanding | $63.6M | $66.6M | $69.3M | $73.1M | $82.5M |
| Weighted average diluted shares outstanding | $64.5M | $67.9M | $70.1M | $73.8M | $83.7M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $137.8M | $126M | $119.4M | $102.8M | $115.3M |
| Net receivables | $2.6B | $2.18B | $2.24B | $2.02B | $1.75B |
| Inventory | $232.1M | $220.9M | $217M | $218.5M | $206.8M |
| Total current assets | $3.41B | $2.82B | $2.81B | $2.54B | $2.26B |
| Property, plant and equipment, net | $7.38B | $6.99B | $6.56B | $6.37B | $6.24B |
| Goodwill and intangible assets | $4.07B | $4.01B | $3.93B | $3.91B | $3.96B |
| Long-term investments | $346.2M | $318.7M | $0.00 | $0.00 | $0.00 |
| Total non-current assets | $12.5B | $11.7B | $11.2B | $11B | $10.8B |
| Total assets | $16B | $14.5B | $14B | $13.5B | $13.1B |
| Accounts payable | $750.1M | $632M | $614M | $636.6M | $658.9M |
| Short-term debt | $821.4M | $114.7M | $198.3M | $149.2M | $112.9M |
| Deferred revenue | $0.00 | $0.00 | $5.38M | $2.4M | $10K |
| Total current liabilities | $3.24B | $2.21B | $2.01B | $1.91B | $1.98B |
| Long-term debt | $4.69B | $4.84B | $5.17B | $5.12B | $4.45B |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $5.31B | $5.5B | $5.75B | $5.61B | $4.91B |
| Capital lease obligations | $426.1M | $450.9M | $454.2M | $463.3M | $369.1M |
| Total liabilities | $8.55B | $7.71B | $7.77B | $7.52B | $6.9B |
| Common stock | $610K | $650K | $670K | $710K | $770K |
| Retained earnings | $7.99B | $7.37B | $6.8B | $5.93B | $6.06B |
| Accumulated other comprehensive income (loss) | -$-717.57M | -$-706.5M | -$-650.6M | -$-9.67M | $30.3M |
| Total equity | $7.41B | $6.76B | $6.2B | $5.97B | $6.2B |
| Total investments | $346.2M | $318.7M | $0.00 | $0.00 | $0.00 |
| Total debt | $5.51B | $4.96B | $5.37B | $5.27B | $4.56B |
| Net debt | $5.37B | $4.83B | $5.25B | $5.17B | $4.44B |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $1.51B | $1.16B | $717.5M | $657M | $987.6M |
| Depreciation and amortization | $618.7M | $584.8M | $568M | $581.9M | $533.2M |
| Stock-based compensation | $95.7M | $99.4M | $87.7M | $85.4M | $73.7M |
| Change in working capital | -$-275.89M | $418.8M | $17.1M | -$-244.35M | -$-736.89M |
| Accounts receivable | -$-317.99M | $67.4M | -$-182.44M | -$-258.34M | -$-8.87M |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Accounts payable | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash provided by operating activities | $1.86B | $2.07B | $1.27B | $996M | $883.7M |
| Investments in property, plant and equipment | -$-1.02B | -$-943.81M | -$-743.05M | -$-734M | -$-855.66M |
| Acquisitions, net | -$-31.94M | -$-18.72M | -$-3.73M | -$-20.31M | -$-105.31M |
| Net cash used for investing activities | -$-1.07B | -$-911.11M | -$-763.27M | -$-647.3M | -$-914.47M |
| Common stock issued | $16.7M | $15.1M | $13.7M | $14.1M | $13.4M |
| Common stock repurchased | -$-967.95M | -$-670.75M | -$-547.36M | -$-832.92M | -$-1.22B |
| Dividends paid | -$-51.27M | -$-53.35M | -$-55.48M | -$-58.45M | -$-65.9M |
| Net cash used for financing activities | -$-749.73M | -$-1.14B | -$-493.94M | -$-318.4M | -$-1.07B |
| Net change in cash | $46.6M | $10.3M | $13.6M | $21.9M | -$-1.1B |
| Cash at end of period | $271.3M | $224.8M | $214.5M | $200.8M | $178.9M |
| Operating cash flow | $1.86B | $2.07B | $1.27B | $996M | $883.7M |
| Capital expenditure | -$-1.02B | -$-943.81M | -$-743.05M | -$-734M | -$-855.66M |
| Free cash flow | $849.3M | $1.12B | $524.7M | $262M | $28M |
Line items
Line items
Line items
About Universal Health Services, Inc.
Universal Health Services, Inc. (UHS), operating through its various divisions, is a healthcare entity that both owns and manages a network of acute care hospitals, along with outpatient and specialized behavioral health treatment centers. Its business operations are strategically bifurcated into two main segments: Acute Care Hospital Services and Behavioral Health Care Services. The hospitals under its management provide a comprehensive spectrum of medical provisions, encompassing general and specialty surgical interventions, internal medicine, obstetrics, urgent and emergency department services, diagnostic imaging (radiology), cancer therapy (oncology), advanced diagnostic procedures, cardiac care, pediatric medicine, pharmaceutical services, and mental health support. As of a reported date of February 24, 2022, the company's significant presence included the ownership or operation of 363 inpatient facilities, complemented by 40 outpatient and other specialized sites. These facilities are distributed across 39 U.S. states, the District of Columbia, the United Kingdom, and Puerto Rico. Beyond direct patient care, UHS also extends into commercial health insurance provision and offers a variety of crucial management support functions. These include centralized procurement, information technology infrastructure, financial oversight and control mechanisms, strategic facilities planning, physician talent acquisition, administrative staff management, marketing initiatives, and public relations efforts. Universal Health Services, Inc. was established in 1978 and maintains its principal executive offices in King of Prussia, Pennsylvania.
- CEO
- Marc D. Miller
- Employees
- 101.5K
- Beta
- 1.07
Included in
Explore
Frequently asked questions
What is the intrinsic value of Universal Health Services, Inc. (UHS)?
Universal Health Services, Inc. (UHS) is currently undervalued based on the InvestorsCraft IC model — IC value is 20–50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is UHS undervalued?
UHS trades at a price of $179.43 (Nov 21, 2026): undervalued — IC value is 20–50% above the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.